MONDAY, May 15, 2023 (HealthDay News) Specific subgroups of patients undergoing total joint arthroplasty (TJA) experience greater benefit from peripheral nerve blocks (PNBs) in terms of reduction in complications, according to a study presented at the Annual Regional Anesthesiology and Acute Pain Medicine Meeting 2023, held from April 20 to 22 in Hollywood, Florida.
MONDAY, May 15, 2023 (HealthDay News) Specific subgroups of patients undergoing total joint arthroplasty (TJA) experience greater benefit from peripheral nerve blocks (PNBs) in terms of reduction in complications,
E-Mail
Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in total knee and total hip replacement surgery. These findings were presented at the 2021 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting.1
Previously available information suggests that oral, IV and topical TXA are all effective at reducing blood loss and drastically reducing blood transfusion rates during and after surgery, but research with direct comparisons for each method is limited. TXA in orthopedic surgery has become the standard of care. However, the most efficient, efficacious and cost effective method of administration remains unknown, said principal investigator Stavros Memtsoudis, MD, PhD, MBA, an anesthesiologist at HSS. The oral administration of TXA is logistically easier, thus reducing the risk of drug errors in the OR.